Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AstraZeneca Biopharmaceutical Manufacturing

Order year

2002

Project type

Expansion

Location

Metro, Montreal, Quebec, Canada

Estimated Investment

$460m

Completion

Phase 1 – 2004/2005; 2006 plant mothballed for foreseeable future

Sponsor

DSM Biologics

Lead engineer / designer

SNC-Lavalin Pharma (SLP)

Building constructor

JE Verreault

Bioreactor design and construction

Biolafitte (Pierre Guérin)

Control systems

SNC-Lavalin pharma (SLP)

Financing

SGF (Societe Generale de Financement du Quebec) - $91m

Province of Quebec - $33m

Type

Recombinant Proteins, Monoclonal Antibodies
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top